AU Patent

AU2013202474A1 — Fused, spirocyclic heteroaromatic compounds for the treatment of bacterial infections

Assigned to AstraZeneca AB · Expires 2013-05-02 · 13y expired

What this patent protects

H:\r\Interwoven\NRPortb\DCC\RBR\5017699_I.DOC.25/03/2013 Abstract The present invention relates to compounds of Formula (I); to pharmaceutically acceptable salts thereof, to methods of using them to treat bacterial infections, and to methods for their 5 preparation.

USPTO Abstract

H:\r\Interwoven\NRPortb\DCC\RBR\5017699_I.DOC.25/03/2013 Abstract The present invention relates to compounds of Formula (I); to pharmaceutically acceptable salts thereof, to methods of using them to treat bacterial infections, and to methods for their 5 preparation.

Drugs covered by this patent

Patent Metadata

Patent number
AU2013202474A1
Jurisdiction
AU
Classification
—
Expires
2013-05-02
Drug substance claim
No
Drug product claim
No
Assignee
AstraZeneca AB
Source
FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.